Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
HIV Medicine|June 13, 2002
Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapyJ Pido-Lopez, A Pires, M Nelson, et al.
Clinical and Experimental Immunology|November 25, 2003
A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapyD Chadwick, J Pido-Lopez, A Pires, et al.
Clinical and Experimental Immunology|October 23, 2002
Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infectionC T Burton, G A D Hardy, A K Sullivan, et al.
Scandinavian Journal of Immunology|June 7, 2003
Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyA K Sullivan, C T Burton, M R Nelson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signalsG Lombardi, R Hargreaves, S Sidhu, et al.
Clinical and Experimental Immunology|October 9, 2012
Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapyA Benlahrech, A Yasmin, S J Westrop, et al.
Clinical and Experimental Immunology|October 30, 1999
Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapyN Imami, G A Hardy, M R Nelson, et al.
Immunology|December 1, 1988
Functional evidence for a monoclonal antibody that binds to the human IL-4 receptorM Larche, J R Lamb, R E O'Hehir, et al.
Clinical and Experimental Immunology|April 16, 2008
Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudyC T Burton, R L Goodall, A Samri, et al.
Clinical and Experimental Immunology|September 17, 2003
Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsivenessG A D Hardy, N Imami, A K Sullivan, et al.
Pageof 5